Measurement of Health-Related Quality of Life in Pediatric Genetic Conditions: A Scoping Review

Author(s)

Smith H1, Hickingbotham MR2, Belanger Deloge R3, Khan F3, Hanmer J4
1Harvard Medical School, Brookline, MA, USA, 2Harvard Medical School, Boston, MA, USA, 3Baylor College of Medicine, Houston, TX, USA, 4University of Pittsburgh, Pittsburgh, PA, USA

Presentation Documents

OBJECTIVES: Measuring health-related quality of life (HRQoL) is key to patient-centered value assessment of genomic medicine interventions, including genomic sequencing and gene-based therapies. Our objective is to describe the empirical literature on HRQoL of pediatric patients with genetic conditions, as well as HRQoL and well-being of their family members.

METHODS: We conducted a scoping review following published methodological guidelines (PRISMA-ScR). We systematically searched PubMed, EMBASE, and grey literature for original research articles published since January 1, 2010 that reported primary data on: 1) pediatric HRQoL for patients with genetic conditions; 2) HRQoL in family members and caregivers of pediatric patients with genetic conditions; 3) family well-being in families affected by pediatric genetic conditions. This review is registered on OSF (https://osf.io/sxk8u/).

RESULTS: Our PubMed search yielded 7,576 records, and our Embase search yielded 13,061 of which 8,299 remained after PubMed duplicates were removed. After title and abstract review, 1,460 records were retained for full-text review. With 67% of full-text screening complete, 689 articles were included for analysis. Articles reported data on pediatric HRQoL (68%), family HRQoL and well-being (20%), or both (12%). Most research was led in the US (34%) or the United Kingdom (7%). The most frequently studied conditions include: sickle cell anemia (13%), cystic fibrosis (13%), hemophilia (9%), Duchenne muscular dystrophy (8%), thalassemia (6%), and Down syndrome (6%). The majority of pediatric HRQoL studies (63%) employed a cross-sectional survey study design, whereas 15% reported data from interventional trials. The Pediatric Quality of Life Inventory (PedsQL) was the most frequently used instrument (24%) to assess pediatric HRQoL.

CONCLUSIONS: While the heterogeneity of conditions and approaches to HRQoL assessment pose challenges for comprehensive evaluations of genomic medicine interventions, there is a growing body of empirical HRQoL literature across a wide range of pediatric genetic conditions.

Conference/Value in Health Info

2023-05, ISPOR 2023, Boston, MA, USA

Value in Health, Volume 26, Issue 6, S2 (June 2023)

Code

PCR128

Topic

Patient-Centered Research

Topic Subcategory

Health State Utilities, Instrument Development, Validation, & Translation, Patient-reported Outcomes & Quality of Life Outcomes, Stated Preference & Patient Satisfaction

Disease

Genetic, Regenerative & Curative Therapies, Pediatrics, Personalized & Precision Medicine

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×